246 related articles for article (PubMed ID: 1401915)
1. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
2. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
5. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
Bazin R; Chevrier MC; Delage R; Lemieux R
Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
[TBL] [Abstract][Full Text] [Related]
6. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
7. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
Tissot JD; Schneider P; Schapira M; Duchosal MA
Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human IgE response in hu-PBL-SCID mice.
Kilchherr E; Mandak V; Wagner K; Heusser CH
Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
10. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes.
Sandhu J; Shpitz B; Gallinger S; Hozumi N
J Immunol; 1994 Apr; 152(8):3806-13. PubMed ID: 8144950
[TBL] [Abstract][Full Text] [Related]
11. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
12. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
13. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
[TBL] [Abstract][Full Text] [Related]
14. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
15. Human Ig production and isotype switching in severe combined immunodeficient-human mice.
Vandekerckhove BA; Jones D; Punnonen J; Schols D; Lin HC; Duncan B; Bacchetta R; de Vries JE; Roncarolo MG
J Immunol; 1993 Jul; 151(1):128-37. PubMed ID: 8326122
[TBL] [Abstract][Full Text] [Related]
16. Xenogeneic PBL-scid mice: their potential and current limitations.
Greenwood JD
Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human anti-mouse idiotypic antibody responses in hu-PBL-SCID mice.
Bitoh S; Lang GM; Sehon AH
Hum Antibodies Hybridomas; 1993 Jul; 4(3):144-51. PubMed ID: 8357958
[TBL] [Abstract][Full Text] [Related]
18. Specific immunosuppression of human anti-murine antibody responses in hu-PBL-SCID mice.
Bitoh S; Lang GM; Kierek-Jaszczuk D; Fujimoto S; Sehon AH
Hum Antibodies Hybridomas; 1993 Jul; 4(3):134-43. PubMed ID: 8357957
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
20. Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells.
Duchosal MA; Mauray S; Rüegg M; Trouillet P; Vallet V; Aarden L; Tissot JD; Schapira M
Cell Immunol; 2001 Jul; 211(1):8-20. PubMed ID: 11585383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
